MedTrace Logo

Elucidating the Mechanism of Remission of Type 2 Diabetes in Morbid Obese Patients After Bariatric Surgery

NCT03038373 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2022-04-06

No results posted yet for this study

Summary

The main aim of this study is to elucidate the mechanism of the remission of type 2 diabetes in the morbid obese patients after laparoscopic sleeve gastrectomy.

Conditions

  • Morbid Obesity
  • Type2 Diabetes

Interventions

PROCEDURE

Laparoscopic Sleeve Gastrectomy

Laparoscopic Sleeve Gastrectomy will be conducted based on standard protocol.

Sponsors & Collaborators

  • Kuwait University

    collaborator OTHER

  • Dasman Diabetes Institute

    lead OTHER

Principal Investigators

  • Hossein Arefanian, PhD · Dasman Diabetes Institute

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2022-06-30
Completion
2024-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03038373 on ClinicalTrials.gov